Markus from Finland

Registered at the short selling broker Capital, 4 minutes ago.

» Try Capital you too
67.7% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

AbbVie, Inc. (ABBV) shares information

Abbvie Inc

24h Change

0.14 %


Live rate: Market closed

Stock data per Friday 25 Nov, 2022

0.23 (+ 0.14%)
US Market is closed

Live Stock price in graph for Abbvie Inc (ABBV)

  • Latest Volume

    1,661,909 (-48.41 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    160.75 USD

  • Today low

    159.241 USD

  • 52 week high

    171.07 USD

  • 52 week low

    110.78 USD

  • YTD Change

    + 22.62 %

Quick links


Latest news about Abbvie Inc

Below you can find the most recent news posts about Abbvie Inc, primarily from US and UK based news sources.

Better Dividend Stock: AbbVie or Viatris?

Saturday, 26 November 2022, 14:15:00
These pharmaceutical companies are profitable and offer above-average dividends.
— The Motley Fool

Want $10,000 in Annual Dividend Income by Retirement? Here”s How Much You Should Invest in AbbVie Today.

Wednesday, 23 November 2022, 17:30:00
This is a stock that rewards long-term investors through continual dividend increases.
— The Motley Fool

Weak Fundamental Momentum Drags AbbVie Inc. (ABBV) Upper

Wednesday, 23 November 2022, 16:00:00
AbbVie Inc. (NYSE:ABBV) has a beta value of 0.66 and has seen 5.35 million shares traded in the last trading session. The company, currently valued at $277.44B, closed the last trade at $159.79 per share which meant it gained $2.68 on the day or 1.71% during that session. The ABBV stock price is -10.09% off … Weak Fundamental Momentum Drags AbbVie Inc. (ABBV) Upper Read More »
— Marketing Sentinel

AbbVie to Present at the Evercore ISI HealthCONx Conference

Wednesday, 23 November 2022, 14:00:00
NORTH CHICAGO, Ill., Nov. 23, 2022 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the 5th Annual Evercore ISI Virtual HealthCONx Conference on Tuesday, November 29, 2022. Rob Michael, vice chairman and president, Jeffrey R. Stewart, executive vice president, commercial…
— PR Newswire

Companies – This Pharmaceutical Company Is A Better Pick Over Johnson & Johnson Stock

Wednesday, 23 November 2022, 12:05:05
While ABBV may outperform JNJ in the next three years, it is helpful to see how Johnson & Johnson”s Peers fare on metrics that matter.
— Business Mag

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: offer a large number of stocks for trading. Register an account today and check if they have ABBV available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.